Clinical trial
Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-lumefantrine and Nevirapine-based Antiretrovirals in HIV-infected Patients With Uncomplicated Falciparum-malaria in Muheza, Northeastern Tanzania
NCT00885287 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-lumefantrine and Nevirapine-based Antiretrovirals in HIV-infected Patients With Uncomplicated Falciparum-malaria in Muheza, Northeastern Tanzania
- Lead sponsor
- University of Copenhagen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- January 31, 2013
- Enrollment
- 830 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.